These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12602393)

  • 21. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
    Weber AA; Hohlfeld T; Harder S
    Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of CYP2C9 genotype on pharmacokinetics: are all NSAIDs the same?
    van Oijen MG; Laheij RJ
    Gastroenterology; 2007 Dec; 133(6):2073-4; author reply 2074-5. PubMed ID: 18054587
    [No Abstract]   [Full Text] [Related]  

  • 23. NSAIDs sometimes cause fatal stomach bleeding.
    Health News; 2005 Nov; 11(11):4-5. PubMed ID: 16294426
    [No Abstract]   [Full Text] [Related]  

  • 24. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal abuse from non-steroidal, anti-inflammatory agents in sport.
    Gerrard DF
    N Z Med J; 1998 Mar; 111(1062):107-8. PubMed ID: 9577467
    [No Abstract]   [Full Text] [Related]  

  • 26. [Non-steroidal anti-inflammatory agents and kidney diseases].
    Baumelou A; Faucher C; Deray G
    Rev Prat; 1986 Oct; 36(45):2677-82. PubMed ID: 3787151
    [No Abstract]   [Full Text] [Related]  

  • 27. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?
    Rahme E; Barkun AN; Toubouti Y; Scalera A; Rochon S; Lelorier J
    Arthritis Rheum; 2007 Jun; 57(5):748-55. PubMed ID: 17530673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of upper gastrointestinal events with the use of various NSAIDs: a case-control study in a general population.
    Helin-Salmivaara A; Saarelainen S; Grönroos JM; Vesalainen R; Klaukka T; Huupponen R
    Scand J Gastroenterol; 2007 Aug; 42(8):923-32. PubMed ID: 17613921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-steroidal anti-inflammatory agents. Principles and rules of their utilization].
    Bannwarth B; Netter P
    Rev Prat; 1992 May; 42(9):1165-70. PubMed ID: 1496248
    [No Abstract]   [Full Text] [Related]  

  • 30. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
    Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ;
    J Am Coll Cardiol; 2008 Oct; 52(18):1502-17. PubMed ID: 19017521
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective study of acute gastrointestinal bleeding attributable to anti-inflammatory drug ingestion in the Yorkshire region of the United Kingdom.
    Lim CH; Heatley RV
    Postgrad Med J; 2005 Apr; 81(954):252-4. PubMed ID: 15811890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
    MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
    [No Abstract]   [Full Text] [Related]  

  • 33. [Kidney damage in treatment with non-steroidal anti-inflammatory agents].
    Raszeja-Wanic B
    Pol Tyg Lek; 1988 Apr; 43(15):467-70. PubMed ID: 3405877
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renal tolerability of non-steroidal drugs (NSAIDS) in newborn infants].
    Fornaro M; Cuzzolin L; Fanos V
    Pediatr Med Chir; 2004; 26(6):423-9. PubMed ID: 16363767
    [No Abstract]   [Full Text] [Related]  

  • 35. [Morphological and pathogenic data on nephropathies due to analgesics].
    Fernández-Sanz J; Carrascal E; González-Campora R; Nogales F; Galera H
    Rev Clin Esp; 1977 Sep; 146(5):265-73. PubMed ID: 303784
    [No Abstract]   [Full Text] [Related]  

  • 36. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
    McCarthy DM
    Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective COX-2 inhibitors: a promise unfulfilled?
    Henry D; McGettigan P
    Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
    [No Abstract]   [Full Text] [Related]  

  • 40. Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis.
    Schifferdecker B; Spodick DH
    Cardiol Rev; 2003; 11(4):211-7. PubMed ID: 12852799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.